Stephen T. Worland, President and CEO at ANADYS PHARMACEUTICALS INC (ANDS), bought 150,000 shares at $2.00 ($306K) on 2007-08-30, disclosed to the SEC on 2007-09-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 124,564 | $249K | 81.4% |
| 2 | $2.08 | 3,120 | $6K | 2.1% |
| 3 | $2.10 | 1,800 | $4K | 1.2% |
| 4 | $2.12 | 6,219 | $13K | 4.3% |
| 5 | $2.13 | 1,042 | $2K | 0.7% |
| 6 | $2.15 | 19 |
| $41 |
| 0.0% |
| 7 | $2.34 | 895 | $2K | 0.7% |
| 8 | $2.35 | 12,341 | $29K | 9.5% |
| Total | $2.04 avg | 150,000 | $306K | 100% |
| Filing → |
| ANDS | SELL | 2006-03-17 | $64K | — | Filing → |